Rosetta Genomics Ltd. Cash and Cash Equivalents
Rosetta Genomics Ltd. had Cash and Cash Equivalents of $1.32 million as of 2017-06-30, per its 6-K filed 2017-10-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2017-10-10
- 2017-06-30: Cash and Cash Equivalents, at Carrying Value $1.32M.
- 2016-12-31: Cash and Cash Equivalents, at Carrying Value $4.59M; Cash and Cash Equivalents, at Carrying Value as first filed $6.16M.
- 2016-06-30: Cash and Cash Equivalents, at Carrying Value $7.82M; Cash and Cash Equivalents, at Carrying Value as first filed $8.05M.
- 2015-12-31: Cash and Cash Equivalents, at Carrying Value $11.11M; Cash and Cash Equivalents, at Carrying Value as first filed $12.45M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2017-06-30 | $1.32M 6-K · filed 2017-10-10 | |
| 2016-12-31 | $4.59M 6-K · filed 2017-10-10 | $6.16M 20-F · filed 2017-03-30 |
| 2016-06-30 | $7.82M 6-K · filed 2017-10-10 | $8.05M 6-K · filed 2016-09-26 |
| 2015-12-31 | $11.11M 6-K · filed 2017-10-10 | $12.45M 20-F · filed 2016-03-23 |
| 2015-06-30 | $4.72M 6-K · filed 2015-10-26 | |
| 2014-12-31 | $7.93M 6-K · filed 2017-10-10 | |
| 2014-06-30 | $9.06M 6-K · filed 2014-09-17 | |
| 2013-12-31 | $16.77M 20-F · filed 2015-03-16 | |
| 2013-06-30 | $18.93M 6-K · filed 2013-09-09 | |
| 2012-12-31 | $30.80M 20-F · filed 2014-03-31 | |
| 2012-06-30 | $6.51M 6-K · filed 2012-09-28 | |
| 2011-12-31 | $735.00K 20-F · filed 2013-03-22 | |
| 2010-12-31 | $2.63M 6-K · filed 2012-12-07 |